Abstrakt

Przypisy

• 1. Balayan M.S., Andjaparidze A.G., Savinskaya S.S., Ketiladze E.S.,Braginsky D.M., Savinov A.P., Poleschuk V.F.: Evidence for a virus innon-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology,1983; 20: 23-31
  Google Scholar
• 2. Boutrouille A., Bakkali-Kassimi L., Crucière C., Pavio N.: Prevalenceof anti-hepatitis E virus antibodies in French blood donors. J.Clin. Microbiol., 2007; 45: 2009-2010
  Google Scholar
• 3. Bura M., Bura A., Adamek A., Michalak M., Marszałek A., HryckiewiczK., Mozer-Lisewska I.: Seroprevalence of hepatitis A virusantibodies (anti-HAV) in adult inhabitants of Wielkopolska region,Poland – the role of simple demographic factors. Ann. Agric. Environ.Med., 2012; 19: 738-741
  Google Scholar
• 4. Buti M., Domínguez A., Plans P., Jardí R., Schaper M., Espuñes J.,Cardeñosa N., Rodríguez-Frías F., Esteban R., Plasència A., SallerasL.: Community-based seroepidemiological survey of hepatitis E virusinfection in Catalonia, Spain. Clin. Vaccine Immunol., 2006; 13:1328-1332
  Google Scholar
• 5. Carmoi T., Safiullah S., Nicand E.: Risk of enterically transmittedhepatitis A, hepatitis E, and Plasmodium falciparum malaria inAfghanistan. Clin. Infect. Dis., 2009; 48: 1800
  Google Scholar
• 6. Christensen P.B., Engle R.E., Hjort C., Homburg K.M., Vach W.,Georgsen J., Purcell R.H.: Time trend of the prevalence of hepatitisE antibodies among farmers and blood donors: a potential zoonosisin Denmark. Clin. Infect. Dis., 2008; 47: 1026-1031
  Google Scholar
• 7. Cleland A., Smith L., Crossan C., Blatchford O., Dalton H.R., ScobieL., Petrik J: Hepatitis E virus in Scottish blood donors. Vox Sang.,2013; 105: 283-289
  Google Scholar
• 8. Dalton H.R., Stableforth W., Hazeldine S., Thurairajah P., RamnaraceR., Warshow U., Ijaz S., Ellis V., Bendall R.: Autochthonoushepatitis E in Southwest England: a comparison with hepatitis A.Eur. J. Clin. Microbiol. Infect. Dis., 2008; 27: 579-585
  Google Scholar
• 9. Dalton H.R., Stableforth W., Thurairajah P., Hazeldine S., RemnaraceR., Usama W., Farrington L., Hamad N., Sieberhagen C., Ellis V.,Mitchell J., Hussaini S.H., Banks M., Ijaz S., Bendall R.P.: Autochthono us hepatitis E in Southwest England: natural history, complicationsand seasonal variation, and hepatitis E virus IgG seroprevalence inblood donors, the elderly and patients with chronic liver disease.Eur. J. Gastroenterol. Hepatol., 2008; 20: 784-790
  Google Scholar
• 10. Faber M.S., Wenzel J.J., Jilg W., Thamm M., Höhle M., Stark K.:Hepatitis E virus seroprevalence among adults, Germany. Emerg.Infect. Dis., 2012; 18: 1654-1657
  Google Scholar
• 11. Gauss A., Wenzel J.J., Flechtenmacher C., Navid M.H., EisenbachC., Jilg W., Stremmel W., Schnitzler P.: Chronic hepatitis E virus infectionin a patient with leukemia and elevated transaminases: a casereport. J. Med. Case Rep., 2012; 6: 334
  Google Scholar
• 12. Jaroszewicz J., Flisiak R., Kalinowska A., Wierzbicka I., ProkopowiczD.: Acute hepatitis E complicated by acute pancreatitis: a casereport and literature review. Pancreas, 2005; 30: 382-384
  Google Scholar
• 13. Jaroszewicz J., Rogalska M., Kalinowska A., Wierzbicka I., ParfieniukA., Flisiak R.: Prevalence of antibodies against hepatitis Evirus among students from India living in Bialystok, Poland. Przegl.Epidemiol., 2008; 62: 433-438
  Google Scholar
• 14. Jeblaoui A., Haim-Boukobza S., Marchadier E., Mokhtari C., Roque-AfonsoA.M.: Genotype 4 hepatitis E virus in France: an autochthonousinfection with a more severe presentation. Clin. Infect.Dis., 2013; 57: e122-e126
  Google Scholar
• 15. Juhl D., Baylis S.A., Blümel J., Görg S., Hennig H.: Seroprevalenceand incidence of hepatitis E virus infection in German blood donors.Transfusion, 2014; 54: 49-56
  Google Scholar
• 16. Kaba M., Brouqui P., Richet H., Badiaga S., Gallian P., Raoult D.,Colson P.: Hepatitis E virus infection in sheltered homeless persons,France. Emerg. Infect. Dis., 2010; 16: 1761-1763
  Google Scholar
• 17. Kaba M., Richet H., Ravaux I., Moreau J., Poizot-Martin I., MotteA., Nicolino-Brunet C., Dignat-George F., Ménard A., Dhiver C.,Brouqui P., Colson P.: Hepatitis E virus infection in patients infectedwith the human immunodeficiency virus. J. Med. Virol., 2011;83: 1704-1716
  Google Scholar
• 18. Kamar N., Bendall R., Legrand-Abravanel F., Xia N.S., Ijaz S., IzopetJ., Dalton H.R.: Hepatitis E. Lancet, 2012; 379: 2477-2488
  Google Scholar
• 19. Kamar N., Selves J., Mansuy J.M., Ouezzani L., Péron J.M., GuitardJ., Cointault O., Esposito L., Abravanel F., Danjoux M., Durand D., VinelJ.P., Izopet J., Rostaing L.: Hepatitis E virus and chronic hepatitisin organ-transplant recipients. N. Engl. J. Med., 2008; 358: 811-817
  Google Scholar
• 20. Kaufmann A., Kenfak-Foguena A., André C., Canellini G., BürgisserP., Moradpour D., DarlingK.E., Cavassini M.: Hepatitis E virusseroprevalence among blood donors in southwest Switzerland. PLoSOne, 2011; 6: e21150
  Google Scholar
• 21. Kenfak-Foguena A., Schöni-Affolter F., Bürgisser P., Witteck A., DarlingK.E., Kovari H., Kaiser L., Evison J.M., Elzi L., Gurter-De La Fuente V.,Jost J., Moradpour D., Abravanel F., Izopet J., Cavassini M., the Swiss HIVCohort Study: Hepatitis E virus seroprevalence and chronic infections inpatients with HIV, Switzerland. Emerg. Infect. Dis., 2011; 17: 1074-1078
  Google Scholar
• 22. Khudyakov Y., Kamili S.: Serological diagnostics of hepatitis Evirus infection. Virus Res., 2011; 161: 84-92
  Google Scholar
• 23. Mansuy J.M., Bendall R., Legrand-Abravanel F., Sauné K., Mié-douge M., Ellis V., Rech H., Destruel F., Kamar N., Dalton H.R., IzopetJ.: Hepatitis E virus antibodies in blood donors, France. Emerg. Infect.Dis., 2011; 17: 2309-2312
  Google Scholar
• 24. Neukam K., Barreiro P., Macías J., Avellón A., Cifuentes C., Martín-CarboneroL., Echevarría J.M., Vargas J., Soriano V., Pineda J.A.:Chronic hepatitis E in HIV patients: rapid progression to cirrhosisand response to oral ribavirin. Clin. Infect. Dis., 2013; 57: 465-468
  Google Scholar
• 25. Olsen B., Axelsson-Olsson D., Thelin A., Weiland O.: Unexpectedhigh prevalence of IgG-antibodies to hepatitis E virus in Swedish pigfarmers and controls. Scand. J. Infect. Dis., 2006; 38: 55-58
  Google Scholar
• 26. Pischke S., Ho H., Urbanek F., Meyer-Olsen D., Suneetha P.V.,Manns M.P., Stoll M., Wedemeyer H.: Hepatitis E in HIV-positivepatients in a low-endemic country. J. Viral Hepat., 2010; 17: 598-599
  Google Scholar
• 27. Renou C., Lafeuillade A., Cadranel J.F., Pavio N., Pariente A.,Allègre T., Poggi C., Pénaranda G., Cordier F., Nicand E.; ANGH. HepatitisE virus in HIV-infected patients. AIDS, 2010; 24: 1493-1499
  Google Scholar
• 28. Rossi-Tamisier M., Moal V., Gerolami R., Colson P.: Discrepancybetween anti-hepatitis E virus immunoglobulin G prevalence assessedby two assays in kidney and liver transplant recipients. J. Clin.Virol., 2013; 56: 62-64
  Google Scholar
• 29. Said B., Ijaz S., Kafatos G., Booth L., Thomas H.L., Walsh A., RamsayM., Morgan D.: Hepatitis E incident investigation team. HepatitisE outbreak on cruise ship. Emerg. Infect. Dis., 2009; 15: 1738-1744
  Google Scholar
• 30. Verhoef L., Koopmans M., Duizer E., Bakker J., Reimerink J., VanPelt W.: Seroprevalence of hepatitis E antibodies and risk profile ofHEV seropositivity in the Netherlands, 2006-2007. Epidemiol. Infect.,2012; 140: 1838-1847
  Google Scholar
• 31. Vernier M., Rossi-Tamisier M., Richet H., Brouqui P., Parola P., BouamriY., Colson P., Gautret P.: Anti-hepatitis E virus antibody prevalencein French expatriate workers. Int. J. Infect. Dis., 2013; 17: e1082-e1084
  Google Scholar
• 32. Versluis J., Pas S.D., Agteresch H.J, de Man R.A., Maaskant J.,Schipper M.E., Osterhaus A.D., Cornelissen J.J., van der Eijk A.A.:Hepatitis E virus: an underestimated opportunistic pathogen inrecipients of allogeneic hematopoietic stem cell transplantation.Blood, 2013; 122: 1079-1086
  Google Scholar
• 33. Wenzel J.J., Preiss J., Schemmerer M., Huber B., Jilg W.: Test performancecharacteristics of Anti-HEV IgG assays strongly influencehepatitis E seroprevalence estimates. J Infect. Dis., 2013; 207: 497-500
  Google Scholar
• 34. Wichmann O., Schimanski S., Koch J., Kohler M., Rothe C., PlentzA., Jilg W., Stark K.: Phylogenetic and case-control study on hepatitisE virus infection in Germany. J. Infect. Dis., 2008; 198: 1732-1741
  Google Scholar
• 35. Zhang J., Zhang X.F., Zhou C., Wang Z.Z., Huang S.J., Yao X., LiangZ.L., Wu T., Li J.X., Yan Q., Yang C.L., Jiang H.M., Huang H.J., Xian Y.L.,Shih J.W., et al.: Protection against hepatitis E virus infection bynaturally acquired and vaccine-induced immunity. Clin. Microbiol.Infect., 2014; 20: O397-O405
  Google Scholar

Pełna treść artykułu